Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2‐F3 fibrosis. Authors' reply

Documenti analoghi

• Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD: Authors' reply
  di: Stuart McPherson, et al.
  Pubblicazione: (2024)
• Letter: Beyond advanced fibrosis—The critical need for assessing NITs performance in identifying F2–F3 fibrosis
  di: Yusuf Yilmaz
  Pubblicazione: (2024)
• Letter: Dietary emulsifiers and intestinal health—The beginning of an evolving story: Authors’ reply
  di: Jessica A. Fitzpatrick, et al.
  Pubblicazione: (2024)
• Letter: Irritable bowel syndrome and antibiotics—Authors' reply
  di: Kyle Staller, et al.
  Pubblicazione: (2024)
• Letter: Using non‐invasive fibrosis tests and emerging diagnostics to enhance the accuracy of liver fibrosis staging in MASLD patients
  di: Wenjun Meng, et al.
  Pubblicazione: (2024)